Researchers develop way to simplify production of 18F-alfatide

04/9/2013 | MolecularImaging.net

Researchers have devised a kit that uses a fluoride-aluminum complex to ease the production of 18F-alfatide, an agent that can zero in on active tumors in squamous or adenomatous lung carcinoma. The method presented a yield of 42.1%, compared with 5% to 25% for the standard method, according to the study published in The Journal of Nuclear Medicine. The agent is being considered as an alternative to 18F-FPPRGD2, which was recently approved. "Because of the simplicity of the method, an advantage is that additional studies can be easily performed in a single day," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ